// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Using mind mapping in learning and teaching rheumatology

Alex Papou - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Value of novel pharmacy medication helpline within the rheumatology department

Rebecca Heaton - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Psychological input in lupus care: A review of a 12 month pilot into psychological support at Barts Lupus Centre

Maria Vidal - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

N/A

Anational survey of the roles and training of healthcare assistants inrheumatology departments

Sandra Robinson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Experience using the NICE CG91 depression screening tool in the rheumatology clinic setting

Lucy Knight - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

N/A

Non-pharmacological interventions for people with fibromyalgia: a systematic review

Christine Rolls - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Fibromyalgia

Methadone hydrochloride

Investigating the disease progression and stability of initial sub-type classification in patients with juvenile idiopathic arthritis after their transfer to adult rheumatology care

Muhamad A Jasim - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Identifying the number of unattended appointments in rheumatology patients pre- and post-transfer to adult health services

Rhona McMillan - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pregabalin has efficacy for hand osteoarthritis pain: a proof-of-concept study using pain sensitisation measures

Nidhi Sofat - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Osteoarthritis 2

Duloxetine

Comparative risk of respiratory depression in patients treated with opioids for non-malignant pain

Meghna Jani - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

Naloxone

What's keeping you awake at night? A study of pain trendography

Nicholas R Fuggle - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comorbid fibromyalgia complicating rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and spondyloarthritis: a systematic review and meta-analysis

Stephen J Duffield - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ankylosing spondylitis

N/A

Musculoskeletalpain predicts health-related job loss among workers aged 50-64 years: is it ahidden impact of osteoarthritis?

Karen Walker-Bone - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

BSR DMARD guidelines and shared prescribing in primary care: is it reliable?

Ghalib Choudhury - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Safety summary results of baricitinib focusing on serious infections events and preselected comorbidities

Bernard Combe - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Baricitinib

Efficacy of sarilumab in patients with rheumatoid arthritis who previously received sarilumab or tocilizumab

Paul Emery - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Tocilizumab

Predictors of presenteeism and absenteeism in patients commencing treatment with methotrexate monotherapy or biologic therapy for rheumatoid arthritis

Sarah Leggett - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

Methotrexate

Liver function abnormalities on conventional DMARDs: results from a contemporary cohort

Katie Bechman - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Sulfasalazine

Pre-treatment anxiety and depression levels are correlated with less improvement in self-reported disease activity in rheumatoid arthritis patients treated with biological therapy: results from the BRAGGSS cohort

Sarah Dyball - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

N/A

Levels of circulating endothelial derived microvesicles in patients with rheumatoid arthritis

Sarah Skeoch - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved